Cargando…

An Aptamer against MNK1 for Non-Small Cell Lung Cancer Treatment

Lung cancer is the leading cause of cancer-related death worldwide. Its late diagnosis and consequently poor survival make necessary the search for new therapeutic targets. The mitogen-activated protein kinase (MAPK)-interacting kinase 1 (MNK1) is overexpressed in lung cancer and correlates with poo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carrión-Marchante, Rebeca, Pinto-Díez, Celia, Klett-Mingo, José Ignacio, Palacios, Esther, Barragán-Usero, Miriam, Pérez-Morgado, M. Isabel, Pascual-Mellado, Manuel, Alcalá, Sonia, Ruiz-Cañas, Laura, Sainz, Bruno, González, Víctor M., Martín, M. Elena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10146192/ https://www.ncbi.nlm.nih.gov/pubmed/37111758 http://dx.doi.org/10.3390/pharmaceutics15041273

Ejemplares similares

Potential Therapeutic Use of Aptamers against HAT1 in Lung Cancer
por: Klett-Mingo, José Ignacio, et al.
Publicado: (2022)

An optimized MNK1b aptamer, apMNKQ2, and its potential use as a therapeutic agent in breast cancer
por: Pinto-Díez, C., et al.
Publicado: (2022)

Characterization of MNK1b DNA Aptamers That Inhibit Proliferation in MDA-MB231 Breast Cancer Cells
por: García-Recio, Eva M, et al.
Publicado: (2016)

Increased expression of MNK1b, the spliced isoform of MNK1, predicts poor prognosis and is associated with triple-negative breast cancer
por: Pinto-Díez, Celia, et al.
Publicado: (2018)

DNA Aptamers against Vaccinia-Related Kinase (VRK) 1 Block Proliferation in MCF7 Breast Cancer Cells
por: Carrión-Marchante, Rebeca, et al.
Publicado: (2021)

Deeping in the Role of the MAP-Kinases Interacting Kinases (MNKs) in Cancer
por: Pinto-Díez, Celia, et al.
Publicado: (2020)

MNK1 and MNK2 expression in the human dorsal root and trigeminal ganglion
por: Shiers, Stephanie, et al.
Publicado: (2023)

MNK1 and MNK2 mediate adverse effects of high-fat feeding in distinct ways
por: Moore, C. E. J., et al.
Publicado: (2016)

MNK Proteins as Therapeutic Targets in Leukemia
por: Mazewski, Candice, et al.
Publicado: (2023)

Role of MAPK/MNK1 signaling in virus replication
por: Kumar, Ram, et al.
Publicado: (2018)

MNK1 and MNK2 enforce expression of E2F1, FOXM1, and WEE1 to drive soft tissue sarcoma
por: Ke, Xin-Yu, et al.
Publicado: (2021)

A role for pre-mNK cells in tumor progression
por: Rosinsky, Carolyn, et al.
Publicado: (2016)

Probing the Anticancer Action of Novel Ferrocene Analogues of MNK Inhibitors
por: Sansook, Supojjanee, et al.
Publicado: (2018)

Oncogenic MNK signalling regulates the metastasis suppressor NDRG1
por: Tian, Shuye, et al.
Publicado: (2017)

Revisiting the Prominent Anti-Tumoral Potential of Pre-mNK Cells
por: Guimont-Desrochers, Fanny, et al.
Publicado: (2013)

Small Molecules Targeting the Inactive Form of the Mnk1/2 Kinases
por: Kannan, Srinivasaraghavan, et al.
Publicado: (2017)

Controlling TIME: How MNK Kinases Function to Shape Tumor Immunity
por: Pham, Thao N.D., et al.
Publicado: (2020)

Overcoming Paradoxical Kinase Priming by a Novel MNK1 Inhibitor
por: Bou-Petit, Elisabeth, et al.
Publicado: (2022)

Scribble Controls Social Motivation Behavior through the Regulation of the ERK/Mnk1 Pathway
por: Moreau, Maïté M., et al.
Publicado: (2022)

Inhibition of Mnk enhances apoptotic activity of cytarabine in acute myeloid leukemia cells
por: Li, Peng, et al.
Publicado: (2016)

MNK2 deficiency potentiates β-cell regeneration via translational regulation
por: Karampelias, Christos, et al.
Publicado: (2022)

The MNK1/2-eIF4E Axis as a Potential Therapeutic Target in Melanoma
por: Prabhu, Sathyen A., et al.
Publicado: (2020)

Disabling MNK protein kinases promotes oxidative metabolism and protects against diet-induced obesity
por: Sandeman, Lauren Y., et al.
Publicado: (2020)

MNK as a potential pharmacological target for suppressing LPS-induced acute lung injury in mice
por: Gao, Jianfeng, et al.
Publicado: (2021)

LK6/Mnk2a is a new kinase of alpha synuclein phosphorylation mediating neurodegeneration
por: Zhang, Shiqing, et al.
Publicado: (2015)

Augmenting MNK1/2 activation by c-FMS proteolysis promotes osteoclastogenesis and arthritic bone erosion
por: Mun, Se Hwan, et al.
Publicado: (2021)

MAP kinase-interacting kinase 1 (MNK1) plays as a tumor suppressor in bladder cancer
por: Chen, Zhuangfei, et al.
Publicado: (2020)

Phosphorylated Mnk1 and eIF4E Are Associated with Lymph Node Metastasis and Poor Prognosis of Nasopharyngeal Carcinoma
por: Zheng, Jun, et al.
Publicado: (2014)

Bilirubin Restrains the Anticancer Effect of Vemurafenib on BRAF-Mutant Melanoma Cells Through ERK-MNK1 Signaling
por: Tan, Yufan, et al.
Publicado: (2021)

Design, Synthesis and Evaluation of Novel Phorbazole C Derivatives as MNK Inhibitors through Virtual High-Throughput Screening
por: Jin, Xin, et al.
Publicado: (2022)

Inhibiting the MNK-eIF4E-β-catenin axis increases the responsiveness of aggressive breast cancer cells to chemotherapy
por: Li, Zhiqiang, et al.
Publicado: (2016)

The Novel Mnk1/2 Degrader and Apoptosis Inducer VNLG-152 Potently Inhibits TNBC Tumor Growth and Metastasis
por: Ramalingam, Senthilmurugan, et al.
Publicado: (2019)

Circadian activities of the brain MNK‐eIF4E signalling axis contribute to diurnal rhythms of some cognitive functions
por: Liu, Dong, et al.
Publicado: (2022)

Spirulina extract improves age-induced vascular dysfunction
por: Majewski, Michal, et al.
Publicado: (2022)

Molecular and Functional Characterization of ssDNA Aptamers that Specifically Bind Leishmania infantum PABP
por: Guerra-Pérez, Natalia, et al.
Publicado: (2015)

Inhibition of Influenza Virus Replication by DNA Aptamers Targeting a Cellular Component of Translation Initiation
por: Rodriguez, Paloma, et al.
Publicado: (2016)

Inhibition of mTORC1 Enhances the Translation of Chikungunya Proteins via the Activation of the MnK/eIF4E Pathway
por: Joubert, Pierre-Emmanuel, et al.
Publicado: (2015)

Design, Synthesis and Bioactivity Evaluation of 4,6-Disubstituted Pyrido[3,2-d]pyrimidine Derivatives as Mnk and HDAC Inhibitors
por: Xing, Kun, et al.
Publicado: (2020)

First‐in‐Human, Healthy Volunteers Integrated Protocol of ETC‐206, an Oral Mnk 1/2 Kinase Inhibitor Oncology Drug
por: Teneggi, Vincenzo, et al.
Publicado: (2019)

Discovery of novel natural products as dual MNK/PIM inhibitors for acute myeloid leukemia treatment: Pharmacophore modeling, molecular docking, and molecular dynamics studies
por: Mohamed, Linda M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jkhhq8uajgd0lk4rlpiuv3t64n